Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 461-470 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism: Differential Effects on PAI-1 Over Time
Nancy J. Brown, Sandeep Kumar, Corrie A. Painter, and Douglas E. Vaughan
Hypertension 2002;40:859-865; published online before print as doi:10.1161/01.HYP.0000040264.15961.48 [Abstract] [Full text]  

Scientific Contributions
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Paolo Mulatero, Franco Rabbia, Alberto Milan, Cristina Paglieri, Fulvio Morello, Livio Chiandussi, and Franco Veglio
Hypertension 2002;40:897-902; published online before print as doi:10.1161/01.HYP.0000038478.59760.41 [Abstract] [Full text]  

Scientific Contributions
Effects of Doxazosin and Propranolol on A2A Adenosine Receptors in Essential Hypertension
Katia Varani, Roberto Manfredini, Valeria Iannotta, Cecilia Pancaldi, Elena Cattabriga, Canan Uluoglu, Pier Andrea Borea, and Francesco Portaluppi
Hypertension 2002;40:909-913; published online before print as doi:10.1161/01.HYP.0000039505.79741.15 [Abstract] [Full text]  

Scientific Contributions
Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular Failure
Klaus Höcherl, Franziska Dreher, Armin Kurtz, and Michael Bucher
Hypertension 2002;40:947-953; published online before print as doi:10.1161/01.HYP.0000041221.13644.B9 [Abstract] [Full text]  

Scientific Contributions
Long-Term Adrenomedullin Administration in Experimental Heart Failure
Miriam T. Rademaker, Chris J. Charles, Eric A. Espiner, M. Gary Nicholls, and A. Mark Richards
Hypertension 2002;40:667-672; published online before print as doi:10.1161/01.HYP.0000037132.90640.26 [Abstract] [Full text]  

Scientific Contributions
Role of Cyclooxygenase-2 in the Prolonged Regulation of Renal Function
Francisco Roig, Maria T. Llinás, Ruth López, and F. Javier Salazar
Hypertension 2002;40:721-728; published online before print as doi:10.1161/01.HYP.0000036451.76323.29 [Abstract] [Full text]  

Scientific Contributions
Leptin Induces Endothelial Cell Migration Through Akt, Which Is Inhibited by PPAR{gamma}-Ligands
Stephan Goetze, Anne Bungenstock, Cornelia Czupalla, Friedrich Eilers, Philipp Stawowy, Ulrich Kintscher, Chantel Spencer-Hänsch, Kristof Graf, Bernd Nürnberg, Ronald E. Law, Eckart Fleck, and Michael Gräfe
Hypertension 2002;40:748-754; published online before print as doi:10.1161/01.HYP.0000035522.63647.D3 [Abstract] [Full text]  

Scientific Contributions
NAD(P)H Oxidase Inhibition Improves Endothelial Function in Rat and Human Blood Vessels
Carlene A. Hamilton, M. Julia Brosnan, Sammy Al-Benna, Geoffrey Berg, and Anna F. Dominiczak
Hypertension 2002;40:755-762; published online before print as doi:10.1161/01.HYP.0000037063.90643.0B [Abstract] [Full text]  

Scientific Contributions
Interaction of Sildenafil With cAMP-Mediated Vasodilation In Vivo
Christoph Schalcher, Karin Schad, Hans Peter Brunner-La Rocca, Ruth Schindler, Erwin Oechslin, Christoph Scharf, Gabor Suetsch, Osmund Bertel, and Wolfgang Kiowski
Hypertension 2002;40:763-767; published online before print as doi:10.1161/01.HYP.0000036027.71527.3E [Abstract] [Full text]  

Scientific Contributions
Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular Failure
Klaus Höcherl, Franziska Dreher, Armin Kurtz, and Michael Bucher
Hypertension published October 28, 2002, doi:10.1161/01.HYP.0000041221.13644.B9 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment